Navigation Links
CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies

LOS ANGELES--(BUSINESS WIRE)--Apr 4, 2007 - CytRx Corporation (NASDAQ:CYTR) today announced positive results of additional animal stroke studies indicating that CytRx's lead drug candidate arimoclomol significantly accelerated the recovery of sensory and motor function in an experimental rat model of stroke, even when treatment was withheld as long as 48 hours after stroke was induced. These data confirm and expand upon preclinical data announced by CytRx in December 2006. Orally-administered arimoclomol is currently in clinical evaluation as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). Based on these impressive results, CytRx will begin planning a potential Phase II clinical trial with arimoclomol in stroke patients.

"These new animal results show that arimoclomol has the potential to help patients recover from the devastating effects of stroke even if the drug is administered well after the actual stroke event," said CytRx President and CEO Steven A. Kriegsman. "We believe this represents a unique advantage of arimoclomol compared with other stroke drug candidates. If efficacious in stroke patients, it would represent a major breakthrough in improving their quality of life. Furthermore, arimoclomol's flexibility for delayed intervention may allow substantial penetration into the $58 billion stroke market because the 'race' to get the patient to an emergency room for treatment may not significantly limit its use, unlike other potential stroke drugs."

In the present study, stroke was induced in rats by blocking blood flow to parts of the brain causing cerebral oxygen deprivation. The rats then received an oral dose of arimoclomol or control substance daily for 35 days, beginning either 6, 12, 24 or 48 hours after stroke was induced. Recovery from stroke was measured by monitoring sensory motor skills. While motor skills declined dramatically in all study rats i
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
2. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
3. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:7/30/2014)... , July 30, 2014 Cynosure, Inc. ... light-based aesthetic treatments for non-invasive and minimally invasive applications, today ... President, Chief Operating Officer and Chief Financial Officer Timothy ... 1, 2014.  Baker, 53, will continue to serve as CFO ... Davin , who remains Chairman and Chief Executive Officer. ...
(Date:7/30/2014)... 30, 2014  Packaging Coordinators, Inc. (PCI) is pleased ... acquire Penn Pharmaceutical Services Limited (Penn Pharma). Penn Pharma is ... the United Kingdom and operates ... and Tokyo , Japan. Penn Pharma ... and Commercial dosage form manufacturing, as well as Clinical ...
(Date:7/30/2014)... , July 30, 2014   Medical Equipment ... have been awarded a Department of Defense (US Army) ... to supply a mobile MRI diagnostic machine and technical ... Business (WOSB) through the Small Business Administration (SBA), Medical ... the field with the latest medical diagnostic equipment. The ...
Breaking Medicine Technology:Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... Reportlinker.com announces that a new market research ... Global Computer Assisted Surgical (CAS) Systems ... This report analyzes the worldwide markets ... Million by the following Product Segments: Surgical Planners ...
... YORK, Feb. 24, 2011 Reportlinker.com announces that a ... Global Drug-Eluting Stents Industry ... report analyzes the worldwide markets for Drug-Eluting Stents in ... the US, Japan, Europe, and Rest of World. Annual ...
Cached Medicine Technology:Reportlinker Adds Global Computer Assisted Surgical (CAS) Systems Industry 2Reportlinker Adds Global Drug-Eluting Stents Industry 2
(Date:7/30/2014)... Ann Arbor, MI, July 31, 2014 Regardless of ... were more likely to develop a drinking problem if ... problems, divorce, and serious financial and legal problems ... by researchers at Columbia University,s Mailman School of Public ... of Preventive Medicine . , Alcohol abuse is a ...
(Date:7/30/2014)... July 31, 2014 “United States Orthopedic Braces ... on the United States Orthopedic Braces and Supports market. The ... (in units) and average price data (in US dollars), within ... , Ankle Braces and Supports , ... and Supports. , Orthotics is a specialty within ...
(Date:7/30/2014)... Daily Gossip mentions that the "Panic Away" ... way to stop anxiety and eliminate all associated symptoms. It ... less than 150,000 people in getting their lives back. , ... anxiety treatment system that will teach sufferers different techniques on ... very simple to access, as it is available in a ...
(Date:7/30/2014)... Ticket Down is a reputable source for ... friendly exhibition match at the Red Bull Arena in ... that was left standing as the best team in the ... largest football competition and even embarrassed the host nation Brazilian ... Germany was led by seven players that called Bayern Munich ...
(Date:7/30/2014)... in sub-Saharan Africa is being revitalized and expanded ... enrollment, broadening curricula, upgrading Internet access and providing ... In the first substantial publication by participants of ... more than 225 authors detailed progress being made ... a supplement being published today by the journal ...
Breaking Medicine News(10 mins):Health News:Veterans' alcohol problems linked to stress on the home front 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 3Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 4Health News:Panic Away Review Reveals How to Stop Anxiety 2Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 2Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 3Health News:Journal supplement details progress in African medical education 2Health News:Journal supplement details progress in African medical education 3
... on added benefits to improve care and quality ... health conditions -, ATLANTA, Oct. 27 ... which begins November 15th, Care,Improvement Plus today announced ... offerings for chronically ill Medicare beneficiaries in Georgia,including ...
... a Federal Office of Men,s Health, WASHINGTON, Oct. ... effort, was administered to the Secretary/ Director,of 50 State ... Office, where appropriate. The survey findings were,presented at the ... October 26th, 2008 and are available at MHN,s booth ...
... WellPoint Institute of Health Care Knowledge Releases Study on the ... ... According to a study released by,the WellPoint Institute of Health ... cost savings,for employers. This second study released by the Institute, ...
... health-care providers may advise their patients to quit smoking, ... their patients through the cessation process. New research presented ... of the American College of Chest Physicians (ACCP), shows ... receive less than 5 hours of training on tobacco ...
... of food and water,contamination, BELLEVILLE, ON, ... (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical company, ... designed to reduce the shedding by cattle ... full licensing approval from the Canadian,Food Inspection ...
... Oct. 27 FGX International,Holdings Limited (Nasdaq: FGXI ... fiscal 2008 financial results after the market closes on,Wednesday, ... call on,Thursday, November 13, 2008 at 8:30 AM EST, ... Financial Officer and Jack Flynn,President to discuss its latest ...
Cached Medicine News:Health News:Care Improvement Plus Launches 2009 Benefits in Georgia 2Health News:New State Public Health Department Survey Results Highlight Available Resources for Men and Women 2Health News:Research Shows Consumer-Directed Health Plans Encourage Preventive Care 2Health News:Research Shows Consumer-Directed Health Plans Encourage Preventive Care 3Health News:Physicians lack smoking cessation training 2Health News:Physicians lack smoking cessation training 3Health News:World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada 2Health News:World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada 3Health News:World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada 4Health News:World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada 5Health News:World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada 6Health News:FGX International to Release Third Quarter Earnings 2
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... operate in a wide variety of applications. • ... manifold can be freely rotated against the handle ... at an optimum angle towards the microtiter plate. ... use of most common pipette tips, and provides ...
Pipetman 8X200 Multichannel Pipette is an eight-channel, fully adjustable, air-displacement pipette having a useful volume range from 20 L to 200 L. Robustwith the usual Gilson qualities this pipette...
... Finnpipette Focus multichannel ... dispensing of reagents into ... for 0.1-10 l volumes. ... of Finnpipette Focus multichannels, ...
Medicine Products: